MASPETH, NY —
OSHA Inspection: MASPETH DENTAL ASSOCIATES
Complaint inspection · Health discipline
At a glance
On , OSHA opened a complaint health inspection of MASPETH DENTAL ASSOCIATES in 66-51 GRAND AVENUE, MASPETH, NY 11378 (NAICS 000000). OSHA activity number 102777653.
OSHA opens inspections for many reasons — routine scheduling under a national or local emphasis program, an employee complaint or referral, or a follow-up after a reported injury. Opening or conducting an inspection is not itself an allegation or a finding that this employer broke any rule; any findings appear as the citations listed below, and citations can be contested, reduced, or withdrawn.
Where did this inspection happen?
- Establishment
- MASPETH DENTAL ASSOCIATES
- Site address
- 66-51 GRAND AVENUE
- City
- MASPETH
- State
- NY
- ZIP
- 11378
What kind of inspection was it?
- Inspection type
- Complaint (B)
- Scope
- Partial (B)
- Discipline
- Health
- Advance notice
- No
- Union status
- B
When did the case open and close?
- Opened
- Closing conference
- Case closed
- Data loaded
Establishment context
- NAICS code
- 000000
- SIC code (legacy)
- 8021
- Employees
- 15
- Ownership type
- A
Citations
7 citations on file for this inspection.
5(a)(1)
- Issued
- Mar 27, 1991
- Abate by
- Apr 15, 1991
- Penalty
- Initial $810 · Current $810
General-duty citation text
Section 5(a)(1) of the Occupational Safety and Health Act of 1970: The employer did not furnish employment and a place of employment which were free from recognized hazards that were causing or likely to cause death or serious physical harm to employees in that employees were exposed to: a) Job Site - On 10/3/90 - Health Care Workers (Dentists, Dental Hygienists, Dental Assistants) working in the Dental Office, did not participate in the training and education segments of the employer's infection control program. The employers infection control program had not been implemented. Employees were not informed of the existence, and availability of a Hepatitis B virus (HBV) vaccination to prevent HBV infection and employee training did not include methods to prevent HBV and Human Immunodeficiency virus (HIV). The hazards of such exposure include, but are not limited to, the onset of clinical symptoms of acute Hepatitis B, anorexia, abdominal pain, jaundice, and the potential for becoming a chronic carrier of the Hepatitis B and/or Human Immunodeficiency virus. The facility's I.C. policy regarding Hepatitis B vaccination shall address all circumstances warranting such vaccinations and shall identify employees at substantial risk of directly contacting body fluids. All Hepatitis B vaccines shall be offered free of charge in amounts and times prescribed by standard medical practice. Follow-Up Procedures after Possible Exposure to HIV/HBV: i) If a health care worker has a percutaneous (needlestick or cut) or mucous membrane (splash to eye, nasal mucosa, or mouth) exposure to blood or body when the worker's skin is chapped, abraded or otherwise non-intact, the source patient shall be informed of the incident and tested for HIV and HBV infections, after consent is obtained. ii) If patient consent is refused or if the source patient tests positive, the health care worker shall be evaluated clinically by HIV antibody testing as soon as possible and advised to report and seek medical evaluation of any acute febrile illness that occurs within 12 weeks after exposure. HIV seronegative workers shall be retested 6 weeks post-exposure and on a periodic basis thereafter (12 weeks and 6 months after exposure). iii) Follow-up procedures shall be taken for health care workers exposed or potentially exposed to HBV. The type of procedures depends on the immunization status of the workers (i.e., whether the HBV vaccination has been received and antibody response is adequate), and the HBV serologic status of the source patient. The C.D.C. Immunization Practices Advisory Committee has published its recommendations regarding HBV post exposure prophylaxis in table format in the June 5, 1985, Morbidity and Mortality Weekly Report. iv) If an employee refuses to submit to the procedures in (ii) or (iii) above, when such procedures are medically indicated, no adverse action may be taken on that ground alone since the procedures are designed for the benefit of the exposed employee. Training and Education of Health Care Workers: i) All high risk health care workers shall receive education on precautionary measures, epidemiology, modes of transmission and prevention of HIV/HBV. Health care workers shall be counseled regarding possible risks to the fetus from HIV/HBV and other associated infectious agents. ii) In addition, such high risk workers must receive training regarding the location and proper use of personal protective equipment. They shall be trained concerning proper work practices and if the facility has implemented them. Tmeployees shall understand the concept of "universal precautions" as it applies to their work practices. They shall be trained about the meaning of color coding or other methods (except tags) used to designate contaminated articles or infectious waste.
Recent events (2)
- — I (S) $810.00
- — Z (S) $810.00
1910.36 B04
- Issued
- Dec 11, 1990
- Abate by
- Dec 19, 1990
- Penalty
- Initial $640 · Current $640
1910.101 B
- Issued
- Dec 11, 1990
- Abate by
- Dec 19, 1990
- Penalty
- Initial $280 · Current $280
1910.132 A
- Issued
- Dec 11, 1990
- Abate by
- Dec 19, 1990
- Penalty
- Initial $640 · Current $640
1910.1200 H
- Issued
- Dec 11, 1990
- Abate by
- Dec 31, 1990
- Penalty
- Initial $280 · Current $280
1904.2 A
- Issued
- Dec 11, 1990
- Abate by
- Jan 15, 1991
1910.20 G02
- Issued
- Dec 11, 1990
- Abate by
- Dec 19, 1990
More inspections in this industry (NAICS 000000)
More inspections in NY
Source
This record is reproduced from the U.S. Department of Labor Open Data API (OSHA inspection dataset). The original IMIS detail view is available at OSHA's Establishment Search for activity number 102777653.
Look up any company's OSHA accident reports by company, or browse severe injury reports by year, state, and company.